Related Experiment Video
Updated: Oct 9, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
[(3)H]ZM241385--an antagonist radioligand for adenosine A(2A) receptors in rat brain
1Neuroscience and Pharmacology, School of Biomedical Sciences, University of Nottingham Medical School, Nottingham NG7 2UH, UK. Steve.Alexander@nottingham.ac.uk
Abstract:
Binding of the novel adenosine A(2A) receptor-selective antagonist radioligand [2-(3)H]-4-(2-[7-amino-2-(2-furyl)(1,2,4)triazolo(2,3-a)(1,3,5,)triazin-5-yl amino]ethyl)phenol ([(3)H]ZM241385) was examined using particulate preparations and frozen sections of rat brain. In membranes from the rat striatum, binding was saturable, reversible and temperature-dependent. Analysis of saturation isotherms indicated that [(3)H]ZM241385 bound with high affinity (K(d) of 0.84 nM), high density (1680 fmol mg protein(-1)) and with a high proportion of specific binding (93% at 1 nM radioligand). Examination of competition profiles indicated that [(3)H]ZM241385 bound to sites with an A(2A) adenosine receptor-like rank order. The presence of guanosine 5'-(3-thio)-triphosphate failed to alter either [(3)H]ZM241385 binding or agonist competition for [(3)H]ZM241385 binding. Autoradiographic analysis of [(3)H]ZM241385 binding to frozen sections of rat brain indicated specific binding to the rat striatum of similar affinity (K(d) of 0.43 nM) and susceptibility to adenosine receptor ligands. At 2 nM [(3)H]ZM241385, specific binding comprised 95+/-1% total binding. In the hippocampus and frontal cortex, binding of [(3)H]ZM241385 failed to saturate and was of lower density. Taken together, these results indicate that [(3)H]ZM241385 should prove to be a useful radioligand in the characterisation of adenosine A(2A) receptors.
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Drugs Affecting Neurotransmitter Release or Uptake

